Author Bernhardt, Günter

1 to 3 of 3 Items
  • 2019 Journal Article | 
    ​ ​Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity​
    Ott, M.; Avendaño-Guzmán, E.; Ullrich, E.; Dreyer, C.; Strauss, J.; Harden, M. & Schön, M. et al.​ (2019) 
    Journal of Neuroinflammation16(1) art. 49​.​ DOI: https://doi.org/10.1186/s12974-019-1437-0 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods​
    Bošnjak, B.; Stein, S. C.; Willenzon, S.; Cordes, A. K.; Puppe, W.; Bernhardt, G. & Ravens, I. et al.​ (2020) 
    Cellular & Molecular Immunology18(4) pp. 936​-944​.​ DOI: https://doi.org/10.1038/s41423-020-00573-9 
    Details  DOI 
  • 2021 Journal Article | 
    ​ ​Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination​
    Hammerschmidt, S. I.; Bosnjak, B.; Bernhardt, G.; Friedrichsen, M.; Ravens, I.; Dopfer-Jablonka, A. & Hoffmann, M. et al.​ (2021) 
    Cellular & Molecular Immunology18(10) pp. 2455​-2456​.​ DOI: https://doi.org/10.1038/s41423-021-00755-z 
    Details  DOI 

Researcher

Sort

issue date

ASC DESC

Items per Page